🔎 Trials Near Me

Gara Jalqabaatti › Myeloma Baay’ee › California › San Francisco

Qorannoo klinikaalii Myeloma Baay’ee San Francisco, CA keessatti

Qorannoo 15 Myeloma Baay’ee f San Francisco fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Namoota walitti qabaa jiraSadarkaa 1
  • University of California San Francisco, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05652335

A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events

Namoota walitti qabaa jiraSadarkaa 2
  • University of California San Francisco, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06500884

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

Namoota walitti qabaa jiraSadarkaa 2
  • University of California San Francisco, San Francisco
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07149857

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 3
  • University of California San Francisco, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07258511

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Namoota walitti qabaa jiraSadarkaa 4
  • University of California San Francisco, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05201781

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1/2
  • UCSF, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07116616

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Kaiser Permanente - South San Francisco Medical Center, San Francisco
  • California Pacific Medical Center Research Institute, San Francisco
  • Kaiser Permanente - San Francisco Medical Center, San Francisco
  • fi 1 dabalataa
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT02693535

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • University of California, San Francisco, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT05892393

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 2
  • UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06297226

A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • UCSF, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07075185

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05850234

Delayed Toxicities Post-CAR-T

Namoota walitti qabaa jiraQorannoo ilaalaa
  • UCSF Medical Center, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07665307

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Bit-2026 · NCT06153251

Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Namoota walitti qabaa jiraSadarkaa 1
  • University of Calfornia, San Francisco, San Francisco
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06348108

Qorannoo Myeloma Baay’ee magaalota biroo keessatti

Qorannoo biroo San Francisco keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.